1) The document defines epilepsy and provides the new ILAE 2017 classification framework for epilepsy syndromes.
2) The classification involves assessing the seizure type, epilepsy type, syndrome, cause, and other relevant impairments.
3) Classifying epilepsy according to this framework helps to determine appropriate testing, treatment, and prognosis for patients. It provides a standardized method for clinicians.
This document describes various seizure semiologies and their associated symptomatogenic zones. It discusses different types of auras including somatosensory, visual, auditory, olfactory, gustatory, autonomic, psychic, and abdominal auras. It also outlines different types of motor seizures including tonic, clonic, tonic-clonic, versive, hypermotor, gelastic, atonic, hypomotor, akinetic, and negative myoclonic seizures. Additional lateralizing signs discussed include dystonic posturing, ictal speech, post-ictal aphasia, Todd's paralysis, post-ictal nose wipe, ictal nystagmus, peri-ictal water
This document provides an overview of epilepsy presented by Dr. KD Dele Ijagbulu. It discusses the introduction and epidemiology of epilepsy, defining it as a neurological disorder characterized by recurrent seizures. It then covers the impact of epilepsy on quality of life, including risks of death from seizures, difficulties with accurate diagnosis, and challenges with medication and treatment options. The document also addresses the aetiology, pathophysiology, classification, diagnosis and differential diagnosis of epilepsy.
This document discusses encephalopathy and summarizes key points about its causes, features on EEG, and types. Encephalopathy is defined as altered brain function resulting in impaired consciousness. It can be caused by metabolic, toxic, infectious, hepatic or other issues. On EEG, encephalopathy typically shows generalized slowing and reduced reactivity. Specific patterns like triphasic waves indicate metabolic encephalopathy. The document outlines different types of encephalopathy and their associated EEG findings to help evaluate severity and guide treatment.
1) Uncontrolled epilepsy can be due to pseudointractability or true refractory epilepsy, requiring different treatment approaches.
2) For uncontrolled epilepsy, the first step is a careful diagnosis to correctly classify the epilepsy type and exclude other conditions, followed by proper antiepileptic drug (AED) selection, dosing, and ensuring compliance.
3) Clobazam is an effective add-on treatment for both generalized and focal epilepsies due to its broad spectrum of action, and can provide long-term seizure control when used as an adjunct to other AEDs.
This document discusses non-epileptic seizures, which are paroxysmal events that resemble epileptic seizures but are not caused by abnormal neuronal activity in the brain. Some key points:
- Non-epileptic seizures can be caused by head injuries, drugs, toxins, preeclampsia, or febrile convulsions in individuals who do not have epilepsy.
- Psychogenic non-epileptic seizures (PNES) are physical manifestations of a psychological disturbance and account for over 90% of misdiagnosed cases originally thought to be epilepsy.
- PNES are diagnosed through ruling out physical causes, patient history, and video EEG monitoring to show no brain activity changes
This document discusses psychogenic nonepileptic seizures (PNES). PNES are characterized by sudden disturbances in motor, sensory, cognitive or emotional functioning that mimic epileptic seizures but are caused by psychological factors rather than abnormal brain activity. The diagnosis of PNES is challenging and often delayed due to the diversity of presentations. Video EEG monitoring is the gold standard for diagnosis and should be performed when PNES is suspected to rule out epilepsy. Treatment involves delivering the diagnosis to patients and managing any underlying psychiatric conditions, usually through psychotherapy. Prognosis depends on factors like duration of illness, motivation for treatment and management of comorbid psychological issues.
This document discusses genetics of epilepsy and provides information on:
1. Over 140 epilepsy-associated genes have been identified and genetic discoveries have revealed diverse genetic mechanisms underlying epilepsy.
2. Current genetic testing can identify pathogenic variants in over 20-50% of epilepsy cases depending on the syndrome and presentation.
3. A wide range of cellular functions and pathways are implicated in genetic epilepsies including ion channels, neurotransmitter receptors, and genes regulating cell growth and synaptic function.
Periodic Lateralized Epileptiform Discharges (PLEDs) are repeating waveforms seen on EEG that occur at regular intervals and are localized to one hemisphere. They are commonly seen after acute cortical injuries like stroke and infections. PLEDs are classified based on their pattern and presence of additional rhythmic discharges. They indicate unstable brain physiology resulting from seizures, injury or metabolic disturbances. While not strictly ictal, PLEDs are associated with increased risk of clinical seizures. Prognosis depends on the underlying cause, with acute severe strokes having the worst outcomes. Treatment involves antiepileptic drugs mainly if clinical seizures are present.
This document describes various seizure semiologies and their associated symptomatogenic zones. It discusses different types of auras including somatosensory, visual, auditory, olfactory, gustatory, autonomic, psychic, and abdominal auras. It also outlines different types of motor seizures including tonic, clonic, tonic-clonic, versive, hypermotor, gelastic, atonic, hypomotor, akinetic, and negative myoclonic seizures. Additional lateralizing signs discussed include dystonic posturing, ictal speech, post-ictal aphasia, Todd's paralysis, post-ictal nose wipe, ictal nystagmus, peri-ictal water
This document provides an overview of epilepsy presented by Dr. KD Dele Ijagbulu. It discusses the introduction and epidemiology of epilepsy, defining it as a neurological disorder characterized by recurrent seizures. It then covers the impact of epilepsy on quality of life, including risks of death from seizures, difficulties with accurate diagnosis, and challenges with medication and treatment options. The document also addresses the aetiology, pathophysiology, classification, diagnosis and differential diagnosis of epilepsy.
This document discusses encephalopathy and summarizes key points about its causes, features on EEG, and types. Encephalopathy is defined as altered brain function resulting in impaired consciousness. It can be caused by metabolic, toxic, infectious, hepatic or other issues. On EEG, encephalopathy typically shows generalized slowing and reduced reactivity. Specific patterns like triphasic waves indicate metabolic encephalopathy. The document outlines different types of encephalopathy and their associated EEG findings to help evaluate severity and guide treatment.
1) Uncontrolled epilepsy can be due to pseudointractability or true refractory epilepsy, requiring different treatment approaches.
2) For uncontrolled epilepsy, the first step is a careful diagnosis to correctly classify the epilepsy type and exclude other conditions, followed by proper antiepileptic drug (AED) selection, dosing, and ensuring compliance.
3) Clobazam is an effective add-on treatment for both generalized and focal epilepsies due to its broad spectrum of action, and can provide long-term seizure control when used as an adjunct to other AEDs.
This document discusses non-epileptic seizures, which are paroxysmal events that resemble epileptic seizures but are not caused by abnormal neuronal activity in the brain. Some key points:
- Non-epileptic seizures can be caused by head injuries, drugs, toxins, preeclampsia, or febrile convulsions in individuals who do not have epilepsy.
- Psychogenic non-epileptic seizures (PNES) are physical manifestations of a psychological disturbance and account for over 90% of misdiagnosed cases originally thought to be epilepsy.
- PNES are diagnosed through ruling out physical causes, patient history, and video EEG monitoring to show no brain activity changes
This document discusses psychogenic nonepileptic seizures (PNES). PNES are characterized by sudden disturbances in motor, sensory, cognitive or emotional functioning that mimic epileptic seizures but are caused by psychological factors rather than abnormal brain activity. The diagnosis of PNES is challenging and often delayed due to the diversity of presentations. Video EEG monitoring is the gold standard for diagnosis and should be performed when PNES is suspected to rule out epilepsy. Treatment involves delivering the diagnosis to patients and managing any underlying psychiatric conditions, usually through psychotherapy. Prognosis depends on factors like duration of illness, motivation for treatment and management of comorbid psychological issues.
This document discusses genetics of epilepsy and provides information on:
1. Over 140 epilepsy-associated genes have been identified and genetic discoveries have revealed diverse genetic mechanisms underlying epilepsy.
2. Current genetic testing can identify pathogenic variants in over 20-50% of epilepsy cases depending on the syndrome and presentation.
3. A wide range of cellular functions and pathways are implicated in genetic epilepsies including ion channels, neurotransmitter receptors, and genes regulating cell growth and synaptic function.
Periodic Lateralized Epileptiform Discharges (PLEDs) are repeating waveforms seen on EEG that occur at regular intervals and are localized to one hemisphere. They are commonly seen after acute cortical injuries like stroke and infections. PLEDs are classified based on their pattern and presence of additional rhythmic discharges. They indicate unstable brain physiology resulting from seizures, injury or metabolic disturbances. While not strictly ictal, PLEDs are associated with increased risk of clinical seizures. Prognosis depends on the underlying cause, with acute severe strokes having the worst outcomes. Treatment involves antiepileptic drugs mainly if clinical seizures are present.
1. Post-stroke neuropsychiatric problems include neurocognitive disorders, depression, anxiety disorders, and psychosis. Vascular neurocognitive disorder is the most common, affecting up to 32% of patients.
2. Post-stroke depression has a prevalence of 29% and is associated with disability, cognitive decline, and worse recovery. Risk factors include personal or family history of psychiatric illness and poor social support.
3. Treatment of post-stroke depression may improve recovery of activities of daily living and decrease mortality over many years compared to untreated depression. Antidepressants like fluoxetine and nortriptyline are effective treatments.
This document discusses the key changes in the 2017 classification of epilepsies by the International League Against Epilepsy (ILAE). It presents the 3-level classification system:
1) Seizure type - Based on where seizures begin in the brain, level of awareness, and other features.
2) Epilepsy type - Focal, generalized, combined, or unknown.
3) Epilepsy syndrome - Specific diagnoses incorporating etiology, seizure types, EEG and imaging features.
The document outlines the changes from prior classifications, new terminology, seizure and epilepsy definitions, etiology categories, and provides examples to illustrate the classification framework.
This document summarizes information about refractory epilepsy. It begins by defining refractory epilepsy as persistent seizures under antiepileptic drug treatment. It then discusses predictive factors of refractory epilepsy like epileptic syndrome, response to previous drugs, age at onset, and structural brain abnormalities. The document outlines evaluation and management approaches including optimizing medical treatment, surgical options like resection or palliation procedures, and other therapies like the ketogenic diet.
Epileptic encephalopathies are a group of heterogeneous brain disorders occurring during brain development that cause frequent abnormal EEG activity leading to cognitive and motor regression. West syndrome presents as infantile spasms, developmental arrest, and the hypsarrhythmia EEG pattern. Lennox-Gastaut syndrome presents between 1-7 years with multiple seizure types and cognitive impairment. Dravet syndrome presents before 1 year with early febrile seizures and later myoclonic seizures. Landau-Kleffner syndrome presents between 2-8 years with acquired aphasia. Panayiotopoulos syndrome presents between 1-14 years with autonomic seizures during sleep. Epilepsy with myoclonic-
This document defines epilepsy as a chronic neurological disorder characterized by recurrent seizures resulting from abnormal neuronal activity in the brain. Seizures can vary in severity from brief periods of lack of awareness to major motor convulsions. Epilepsy is classified based on whether seizures originate in one area of the brain (focal) or engage both hemispheres (generalized). Common causes include trauma, tumors, infections, genetic factors, and metabolic imbalances. Diagnostic workup may include EEG, CT/MRI, and genetic testing. Treatment primarily involves anti-seizure medications, while refractory cases may be treated with surgery to remove the seizure focus.
Schizophrenia is linked to over a dozen genes that regulate neuronal connectivity, synaptogenesis, NMDA glutamate receptors, and neuronal migration. It is also regulated by four genes: BDNF, Dysbindin, DISC1, and neuregulin. Schizophrenia is postulated to have four stages: stage 1 from birth to 15 with full functioning; stage 2 from 15-20 with subtle symptoms; stage 3 from 20-40 with acute positive symptoms and relapses; and stage 4 from 40-60 with prominent negative and cognitive symptoms and continuing disability.
Temporal lobe epilepsy is one of the most common forms of epilepsy. It can be caused by hippocampal sclerosis or lesions in the temporal lobe. Hippocampal sclerosis involves neuronal loss and gliosis in the hippocampus and is the most common pathological finding in temporal lobe epilepsy patients. Interictal EEG findings like temporal intermittent rhythmic delta activity and temporal sharp waves help lateralize the seizure focus. Video EEG monitoring helps capture seizures and interictal discharges. Treatment involves antiepileptic drugs and potentially resective surgery for drug-resistant cases.
1. PLEDs (Periodic Lateralized Epileptiform Discharges) are a pattern seen on EEG characterized by periodic discharges that are lateralized to one hemisphere.
2. They are commonly seen in conditions involving acute brain injury or inflammation such as stroke, encephalitis, tumors, or hypoxic ischemic encephalopathy.
3. PLEDs are associated with a risk of seizures but generally indicate an unstable brain state that will improve over time as the underlying condition resolves. Prognosis depends on the specific cause.
1. The document defines abnormal EEG patterns (AEPs) and describes two main types: non-epileptiform and epileptiform.
2. Non-epileptiform patterns include slow waves, which can be focal or diffuse, and amplitude/frequency asymmetry. Epileptiform patterns consist of spike and sharp waves that can be focal or generalized.
3. Specific AEPs are described such as benign rolandic epilepsy, 3/sec spike-wave, periodic lateralized epileptiform discharges, and others associated with various neurological conditions.
1. The document outlines guidelines for treating schizophrenia in three phases: acute, stabilization, and stable.
2. During the acute phase, treatment focuses on ensuring safety, comprehensive assessment, and prompt treatment of psychotic symptoms. Antipsychotics are the primary treatment.
3. The stabilization phase aims to achieve sustained symptom remission and transition patients successfully into the community with continued support.
4. During the stable phase, treatment focuses on managing side effects, monitoring adherence, and identifying relapse risk factors to prevent recurrence of psychosis. Continued medication is emphasized for long-term prevention of relapse.
The document defines status epilepticus as seizure activity that continues for 30 minutes or more, or recurrent seizures without recovery in between. It can be caused by factors like febrile illness in children, anticonvulsant withdrawal, metabolic disturbances, drugs or alcohol, infections, tumors or head trauma. Treatment involves stabilizing the patient, administering benzodiazepines like lorazepam intravenously to stop seizures, followed by anti-seizure drugs like fosphenytoin or phenobarbital if needed. Complications can include cardiac, respiratory or metabolic issues if not treated promptly.
This document provides definitions and information about seizures and epilepsy. It defines a seizure as a sudden wave of synchronous electrical activity in the brain that affects how a person feels or acts for a short time. Epilepsy is defined as a condition that affects the central nervous system and requires a person to have had at least two seizures not caused by a known medical condition or extremely low blood sugar. The document discusses different types of seizures including partial and generalized seizures, as well as diagnostic testing and treatment options for epilepsy.
This document provides an overview of panic disorder (PD), including its definition, symptoms, risk factors, differences from panic attacks, causes, effects on schooling, outcomes, diagnostic criteria, reasons for hospitalization, conditions that mimic it, suicide rates, and treatment goals. PD is defined as recurrent unexpected panic attacks along with fears about future attacks. It has biological, pharmacological, cognitive, and chronic illness-related causes. Treatment aims to reduce attack frequency, intensity, anticipatory anxiety, and phobic avoidance.
This document defines seizures and epilepsy, describes different types of seizures, and outlines evaluation and treatment approaches. It summarizes that seizures are caused by sudden bursts of electrical activity in the brain, epilepsy is defined as two or more unprovoked seizures, and evaluation involves medical history, physical exam, EEG, and sometimes neuroimaging to classify seizures and determine underlying causes and treatment.
Epilepsy is a neurological disorder that causes recurring seizures and affects over 5 million people in the US. Seizures occur when brain cells misfire and send too many electrical signals at once, causing changes in awareness, movement, or sensation. While epilepsy can be caused by head injuries or other brain damage, in many cases the cause is unknown. The Epilepsy Foundation provides resources and support for those affected by epilepsy and works to reduce the stigma around this common condition.
This document summarizes the management of acute ischemic stroke patients. It discusses the types of strokes, prehospital identification and scales used to identify strokes, the evaluation process in the emergency department, differential diagnosis, and management strategies. The key points are:
1) Prehospital scales like the Los Angeles Prehospital Stroke Screen and Cincinnati Prehospital Stroke Scale are used by EMS to rapidly identify acute strokes.
2) In the emergency department, patients receive an evaluation including vital signs, glucose testing, neurological exam using the NIH Stroke Scale, and non-contrast head CT to identify the type and location of stroke.
3) Differential diagnosis for acute neurological symptoms includes conditions like seizures, intrac
Psychogenic nonepileptic seizures (PNES) are not caused by neurological dysfunction but are psychologically determined. Common psychiatric conditions associated with PNES include depression, anxiety, somatoform disorder, PTSD, dissociative disorder, and various personality disorders. A history of sexual or physical abuse is reported in one-third to half of PNES patients. PNES episodes typically last longer than 2 minutes, involve eyes being closed and variable motor movements rather than stereotyped behaviors seen in epilepsy. Diagnosis involves distinguishing PNES from epileptic seizures based on clinical features during and after episodes.
The document discusses various epileptic syndromes categorized by age of onset - neonatal, infancy, childhood, adolescence-adult. For each syndrome, it provides information on defining features, age of onset, seizure types, EEG patterns, treatment and prognosis. The syndromes discussed include benign familial neonatal epilepsy, Ohtahara syndrome, West syndrome, Panayiotopoulos syndrome, Lennox-Gastaut syndrome, juvenile myoclonic epilepsy and others.
This document provides an overview of the history, definitions, classification, epidemiology and psychiatric disorders associated with epilepsy. It discusses how epilepsy was viewed in ancient times as a supernatural condition and outlines key developments in understanding including Hippocrates' view of it as a brain disorder. It defines terms like seizure, aura and epilepsy and classifies seizure types. Statistics on prevalence and risk factors for psychopathology in epilepsy are presented. Specific psychiatric conditions like depression, anxiety and inter-ictal psychosis are also examined.
Epilepsy syndromes can be categorized based on age of onset from neonates to childhood. Syndromes include self-limited, developmental and epileptic encephalopathies, and genetic generalized epilepsies. Syndromes are defined by seizure type, EEG findings, development, and treatment response/prognosis. Examples provided include benign familial neonatal epilepsy, Dravet syndrome, childhood absence epilepsy, Lennox-Gastaut syndrome, and Landau-Kleffner syndrome.
The document discusses the classification, diagnosis, and management of seizures, epilepsy, and status epilepticus in children. It covers the definitions and approaches for a child presenting with a first seizure, an established diagnosis of epilepsy, or status epilepticus. Key points include classifying seizures as focal or generalized onset, evaluating first seizures, investigating and treating epilepsy, and defining status epilepticus as continuous seizure activity lasting more than five minutes or two or more seizures without recovery between them.
This document outlines a proposed classification system for epilepsies from the International League Against Epilepsy (ILAE). The system aims to provide clear and transparent terminology for clinical diagnosis. It classifies epilepsies based on etiology, seizure type, epilepsy type, epilepsy syndrome, and developmental or epileptic encephalopathies. The classification seeks to simplify frameworks, consider etiology at all stages, and update terminology to reflect current scientific advances and clinical practice.
1. Post-stroke neuropsychiatric problems include neurocognitive disorders, depression, anxiety disorders, and psychosis. Vascular neurocognitive disorder is the most common, affecting up to 32% of patients.
2. Post-stroke depression has a prevalence of 29% and is associated with disability, cognitive decline, and worse recovery. Risk factors include personal or family history of psychiatric illness and poor social support.
3. Treatment of post-stroke depression may improve recovery of activities of daily living and decrease mortality over many years compared to untreated depression. Antidepressants like fluoxetine and nortriptyline are effective treatments.
This document discusses the key changes in the 2017 classification of epilepsies by the International League Against Epilepsy (ILAE). It presents the 3-level classification system:
1) Seizure type - Based on where seizures begin in the brain, level of awareness, and other features.
2) Epilepsy type - Focal, generalized, combined, or unknown.
3) Epilepsy syndrome - Specific diagnoses incorporating etiology, seizure types, EEG and imaging features.
The document outlines the changes from prior classifications, new terminology, seizure and epilepsy definitions, etiology categories, and provides examples to illustrate the classification framework.
This document summarizes information about refractory epilepsy. It begins by defining refractory epilepsy as persistent seizures under antiepileptic drug treatment. It then discusses predictive factors of refractory epilepsy like epileptic syndrome, response to previous drugs, age at onset, and structural brain abnormalities. The document outlines evaluation and management approaches including optimizing medical treatment, surgical options like resection or palliation procedures, and other therapies like the ketogenic diet.
Epileptic encephalopathies are a group of heterogeneous brain disorders occurring during brain development that cause frequent abnormal EEG activity leading to cognitive and motor regression. West syndrome presents as infantile spasms, developmental arrest, and the hypsarrhythmia EEG pattern. Lennox-Gastaut syndrome presents between 1-7 years with multiple seizure types and cognitive impairment. Dravet syndrome presents before 1 year with early febrile seizures and later myoclonic seizures. Landau-Kleffner syndrome presents between 2-8 years with acquired aphasia. Panayiotopoulos syndrome presents between 1-14 years with autonomic seizures during sleep. Epilepsy with myoclonic-
This document defines epilepsy as a chronic neurological disorder characterized by recurrent seizures resulting from abnormal neuronal activity in the brain. Seizures can vary in severity from brief periods of lack of awareness to major motor convulsions. Epilepsy is classified based on whether seizures originate in one area of the brain (focal) or engage both hemispheres (generalized). Common causes include trauma, tumors, infections, genetic factors, and metabolic imbalances. Diagnostic workup may include EEG, CT/MRI, and genetic testing. Treatment primarily involves anti-seizure medications, while refractory cases may be treated with surgery to remove the seizure focus.
Schizophrenia is linked to over a dozen genes that regulate neuronal connectivity, synaptogenesis, NMDA glutamate receptors, and neuronal migration. It is also regulated by four genes: BDNF, Dysbindin, DISC1, and neuregulin. Schizophrenia is postulated to have four stages: stage 1 from birth to 15 with full functioning; stage 2 from 15-20 with subtle symptoms; stage 3 from 20-40 with acute positive symptoms and relapses; and stage 4 from 40-60 with prominent negative and cognitive symptoms and continuing disability.
Temporal lobe epilepsy is one of the most common forms of epilepsy. It can be caused by hippocampal sclerosis or lesions in the temporal lobe. Hippocampal sclerosis involves neuronal loss and gliosis in the hippocampus and is the most common pathological finding in temporal lobe epilepsy patients. Interictal EEG findings like temporal intermittent rhythmic delta activity and temporal sharp waves help lateralize the seizure focus. Video EEG monitoring helps capture seizures and interictal discharges. Treatment involves antiepileptic drugs and potentially resective surgery for drug-resistant cases.
1. PLEDs (Periodic Lateralized Epileptiform Discharges) are a pattern seen on EEG characterized by periodic discharges that are lateralized to one hemisphere.
2. They are commonly seen in conditions involving acute brain injury or inflammation such as stroke, encephalitis, tumors, or hypoxic ischemic encephalopathy.
3. PLEDs are associated with a risk of seizures but generally indicate an unstable brain state that will improve over time as the underlying condition resolves. Prognosis depends on the specific cause.
1. The document defines abnormal EEG patterns (AEPs) and describes two main types: non-epileptiform and epileptiform.
2. Non-epileptiform patterns include slow waves, which can be focal or diffuse, and amplitude/frequency asymmetry. Epileptiform patterns consist of spike and sharp waves that can be focal or generalized.
3. Specific AEPs are described such as benign rolandic epilepsy, 3/sec spike-wave, periodic lateralized epileptiform discharges, and others associated with various neurological conditions.
1. The document outlines guidelines for treating schizophrenia in three phases: acute, stabilization, and stable.
2. During the acute phase, treatment focuses on ensuring safety, comprehensive assessment, and prompt treatment of psychotic symptoms. Antipsychotics are the primary treatment.
3. The stabilization phase aims to achieve sustained symptom remission and transition patients successfully into the community with continued support.
4. During the stable phase, treatment focuses on managing side effects, monitoring adherence, and identifying relapse risk factors to prevent recurrence of psychosis. Continued medication is emphasized for long-term prevention of relapse.
The document defines status epilepticus as seizure activity that continues for 30 minutes or more, or recurrent seizures without recovery in between. It can be caused by factors like febrile illness in children, anticonvulsant withdrawal, metabolic disturbances, drugs or alcohol, infections, tumors or head trauma. Treatment involves stabilizing the patient, administering benzodiazepines like lorazepam intravenously to stop seizures, followed by anti-seizure drugs like fosphenytoin or phenobarbital if needed. Complications can include cardiac, respiratory or metabolic issues if not treated promptly.
This document provides definitions and information about seizures and epilepsy. It defines a seizure as a sudden wave of synchronous electrical activity in the brain that affects how a person feels or acts for a short time. Epilepsy is defined as a condition that affects the central nervous system and requires a person to have had at least two seizures not caused by a known medical condition or extremely low blood sugar. The document discusses different types of seizures including partial and generalized seizures, as well as diagnostic testing and treatment options for epilepsy.
This document provides an overview of panic disorder (PD), including its definition, symptoms, risk factors, differences from panic attacks, causes, effects on schooling, outcomes, diagnostic criteria, reasons for hospitalization, conditions that mimic it, suicide rates, and treatment goals. PD is defined as recurrent unexpected panic attacks along with fears about future attacks. It has biological, pharmacological, cognitive, and chronic illness-related causes. Treatment aims to reduce attack frequency, intensity, anticipatory anxiety, and phobic avoidance.
This document defines seizures and epilepsy, describes different types of seizures, and outlines evaluation and treatment approaches. It summarizes that seizures are caused by sudden bursts of electrical activity in the brain, epilepsy is defined as two or more unprovoked seizures, and evaluation involves medical history, physical exam, EEG, and sometimes neuroimaging to classify seizures and determine underlying causes and treatment.
Epilepsy is a neurological disorder that causes recurring seizures and affects over 5 million people in the US. Seizures occur when brain cells misfire and send too many electrical signals at once, causing changes in awareness, movement, or sensation. While epilepsy can be caused by head injuries or other brain damage, in many cases the cause is unknown. The Epilepsy Foundation provides resources and support for those affected by epilepsy and works to reduce the stigma around this common condition.
This document summarizes the management of acute ischemic stroke patients. It discusses the types of strokes, prehospital identification and scales used to identify strokes, the evaluation process in the emergency department, differential diagnosis, and management strategies. The key points are:
1) Prehospital scales like the Los Angeles Prehospital Stroke Screen and Cincinnati Prehospital Stroke Scale are used by EMS to rapidly identify acute strokes.
2) In the emergency department, patients receive an evaluation including vital signs, glucose testing, neurological exam using the NIH Stroke Scale, and non-contrast head CT to identify the type and location of stroke.
3) Differential diagnosis for acute neurological symptoms includes conditions like seizures, intrac
Psychogenic nonepileptic seizures (PNES) are not caused by neurological dysfunction but are psychologically determined. Common psychiatric conditions associated with PNES include depression, anxiety, somatoform disorder, PTSD, dissociative disorder, and various personality disorders. A history of sexual or physical abuse is reported in one-third to half of PNES patients. PNES episodes typically last longer than 2 minutes, involve eyes being closed and variable motor movements rather than stereotyped behaviors seen in epilepsy. Diagnosis involves distinguishing PNES from epileptic seizures based on clinical features during and after episodes.
The document discusses various epileptic syndromes categorized by age of onset - neonatal, infancy, childhood, adolescence-adult. For each syndrome, it provides information on defining features, age of onset, seizure types, EEG patterns, treatment and prognosis. The syndromes discussed include benign familial neonatal epilepsy, Ohtahara syndrome, West syndrome, Panayiotopoulos syndrome, Lennox-Gastaut syndrome, juvenile myoclonic epilepsy and others.
This document provides an overview of the history, definitions, classification, epidemiology and psychiatric disorders associated with epilepsy. It discusses how epilepsy was viewed in ancient times as a supernatural condition and outlines key developments in understanding including Hippocrates' view of it as a brain disorder. It defines terms like seizure, aura and epilepsy and classifies seizure types. Statistics on prevalence and risk factors for psychopathology in epilepsy are presented. Specific psychiatric conditions like depression, anxiety and inter-ictal psychosis are also examined.
Epilepsy syndromes can be categorized based on age of onset from neonates to childhood. Syndromes include self-limited, developmental and epileptic encephalopathies, and genetic generalized epilepsies. Syndromes are defined by seizure type, EEG findings, development, and treatment response/prognosis. Examples provided include benign familial neonatal epilepsy, Dravet syndrome, childhood absence epilepsy, Lennox-Gastaut syndrome, and Landau-Kleffner syndrome.
The document discusses the classification, diagnosis, and management of seizures, epilepsy, and status epilepticus in children. It covers the definitions and approaches for a child presenting with a first seizure, an established diagnosis of epilepsy, or status epilepticus. Key points include classifying seizures as focal or generalized onset, evaluating first seizures, investigating and treating epilepsy, and defining status epilepticus as continuous seizure activity lasting more than five minutes or two or more seizures without recovery between them.
This document outlines a proposed classification system for epilepsies from the International League Against Epilepsy (ILAE). The system aims to provide clear and transparent terminology for clinical diagnosis. It classifies epilepsies based on etiology, seizure type, epilepsy type, epilepsy syndrome, and developmental or epileptic encephalopathies. The classification seeks to simplify frameworks, consider etiology at all stages, and update terminology to reflect current scientific advances and clinical practice.
Epilepsy is a chronic neurological condition characterized by recurrent, unprovoked seizures. It can be classified as generalized seizures originating from both hemispheres of the brain or focal seizures arising from one hemisphere. The majority of childhood epilepsy cases are idiopathic, while secondary causes include brain malformations, infections, tumors or trauma. Diagnosis involves clinical history and examination along with an EEG. Treatment primarily consists of antiepileptic drug monotherapy tailored to the seizure type, with the goal of seizure control and prevention of recurrence. Status epilepticus is a medical emergency defined by prolonged or repeated seizures, and requires rapid treatment to prevent neurological injury.
This document provides an overview of seizures and epilepsy. It defines seizures and epilepsy, discusses epidemiology, classification of seizures, causes, pathogenesis, clinical evaluation, and management. Seizures are caused by abnormal neuronal activity in the brain, while epilepsy is defined as two or more unprovoked seizures. Evaluation involves a detailed history, physical exam, EEG, and imaging tests. Management depends on seizure type and underlying cause, and may involve lifestyle changes and antiepileptic medications.
Dr. kristen park kcnq2 Cure summit parent track learn more at kcnq2cure.orgscottyandjim
1. The document discusses the classification and treatment of epilepsies, focusing on epileptic encephalopathies like KCNQ2E.
2. Epileptic encephalopathies are characterized by frequent seizures, abnormal EEG patterns, developmental impairment, and are often resistant to treatment.
3. Treatment aims to minimize seizures and side effects while optimizing quality of life, and may include medications, dietary therapies, devices, and early intervention.
This document provides information on genetic epilepsy and juvenile myoclonic epilepsy. It defines epilepsy and describes its various classifications including idiopathic, symptomatic and cryptogenic epilepsy. Juvenile myoclonic epilepsy is discussed in detail, including its genetics, clinical manifestations such as myoclonic jerks and absence seizures, diagnosis through EEG findings, and treatment options involving anti-seizure medications. Circumstances for genetic testing in epilepsy cases are outlined.
This document discusses convulsive status epilepticus (CSE). It notes that the worldwide incidence of CSE is highest in children and the elderly, with mortality rates ranging from 10.5-28% and neurological sequelae occurring in 11-16% of patients. The most common causes of CSE are listed as low anti-epileptic drug levels, stroke, alcohol withdrawal, anoxic brain injury, and metabolic disturbances. The document provides details on the definition, types, risk factors, complications, management, and treatment of CSE.
This document provides an overview of epilepsy, including definitions, types of seizures, diagnosis, treatment and implications. It defines epilepsy as recurring unprovoked seizures and describes the different types of generalized and focal seizures. It outlines the diagnostic process including clinical evaluation, EEG and neuroimaging. It discusses treatment with antiepileptic drugs and risk of seizure recurrence. The document also covers refractory epilepsy, implications of an epilepsy diagnosis, and provides statistics on treatment effectiveness.
2017 revised ILEA classification of seizuresDhaval Modi
The document summarizes the 2017 revised classification of seizures by the International League Against Epilepsy (ILAE). The classification was updated to better reflect current understanding and includes the following key changes:
1. Seizures are classified based on where they begin in the brain, level of awareness during the seizure, and other features.
2. New terminology is introduced, such as "focal aware" and "focal impaired awareness" seizures instead of "simple partial" and "complex partial".
3. Epilepsy syndromes are defined as clusters of features rather than approved entities. Old terms like "idiopathic generalized epilepsies" are replaced.
4. The classification aims to be applicable
This document discusses epilepsy in children, including types, clinical presentation, investigations, management, and complications. It provides an overview of seizure types and classifications, the etiology and syndromes of epilepsy in children, how epilepsy presents clinically and is evaluated, and guidelines for treatment and counseling to control seizures and prevent complications. Key aspects covered include acute seizure management, anti-epileptic medications, status epilepticus, and the potential neurological and developmental impacts of uncontrolled epilepsy.
Epilepsy by hosam Maarouf Alhussin.. typesHosamAlhussin
Epilepsy is defined as two or more unprovoked seizures occurring more than 24 hours apart or one unprovoked seizure with a high risk of further seizures. Seizures occur due to abnormal excessive firing of neurons in the brain. Epilepsy can be focal, originating in one area of the brain, or generalized, engaging networks across both hemispheres. Treatment involves medications to prevent seizures as well as surgery for drug-resistant focal epilepsies.
This document provides an overview of evaluating the etiology of seizures. It discusses the initial evaluation steps, including distinguishing epileptic from non-epileptic events. It reviews diagnostic investigations like imaging, EEG, and bloodwork. Common structural etiologies and epilepsy syndromes are described. The document emphasizes performing a thorough history, physical exam, and targeted workup to identify underlying causes and guide treatment and prognosis.
This document discusses seizures and epilepsy in children. It defines a seizure as abnormal excessive neuronal activity in the brain and epilepsy as two or more unprovoked seizures occurring more than 24 hours apart. Seizures can be focal, originating in one area of the brain, or generalized, involving both hemispheres simultaneously. Epilepsy syndromes are described. Imaging and EEG play roles in evaluating seizures, with MRI being preferred and EEG showing localized or generalized abnormalities.
This document provides an overview of epilepsy including definitions, types of seizures, causes, risk factors, diagnostic approach, treatment options, and antiepileptic drug management. Key points include: epilepsy is defined as recurrent unprovoked seizures; status epilepticus is a medical emergency; common causes include vascular, infectious, traumatic, autoimmune and metabolic factors; evaluation involves clinical history, EEG, MRI and video telemetry; treatment involves acute seizure control and chronic antiepileptic drug management to prevent recurrence; drug selection depends on seizure type and side effect profile; surgery is an option for drug-resistant cases.
The document discusses the central nervous system and epilepsy. It defines epilepsy as a chronic disorder characterized by unpredictable seizures caused by abnormal neuronal discharge. Seizures are categorized as either partial or generalized based on their origin and presentation. The document outlines various epilepsy syndromes and treatments. It describes the mechanisms of several first-generation and second-generation anticonvulsant drugs, including sodium channel blockade, potentiation of GABA, and blockade of glutamate receptors. The classification and treatment of different seizure types is discussed.
This document discusses epileptic encephalopathies, which are a group of heterogeneous brain disorders occurring during brain development where epileptiform activity contributes to cognitive and behavioral regression beyond the underlying pathology. It defines and classifies several early-onset epileptic encephalopathy syndromes according to age of onset such as Ohtahara syndrome, early myoclonic encephalopathy, West syndrome, Dravet syndrome, Lennox-Gastaut syndrome, and myoclonic-astatic epilepsy. It provides details on clinical presentation, EEG features, causes, and treatment approaches for each condition.
West syndrome, also known as infantile spasms, is a severe childhood epileptic encephalopathy characterized by epileptic spasms, hypsarrhythmia on EEG, and developmental arrest or retardation. It affects 3 to 5 per 10,000 live births and is classified as a developmental and epileptic encephalopathy. The prognosis is generally poor but depends on the underlying etiology. Early identification of subtle spasms and prompt treatment, typically with steroids, is important to optimize developmental outcomes as delayed treatment can negatively impact cognitive development. Parental education on symptom recognition is also key to preventing poor long-term outcomes in cases of unknown etiology.
Epilepsy is a chronic neurological condition characterized by recurrent seizures. The majority of childhood epilepsy is idiopathic or genetic in origin. Seizures can be generalized, arising from both hemispheres, or focal, arising from one hemisphere. Common generalized seizures include tonic-clonic, absence, and myoclonic seizures. Diagnosis involves a clinical history and may include EEG and imaging. Treatment primarily involves antiepileptic drug therapy to control seizures.
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
2. DEFINITION
Epilepsy is a disorder of the brain characterized by an enduring
predisposition to generate epileptic seizures and by the neurobiologic,
cognitive, psychological, and social consequences of this condition. •
An epileptic seizure is the transient occurrence of clinical
manifestation of abnormal excessive or synchronous neuronal activity
in the brain.
An epileptic syndrome is an epileptic disorder characterized by a
cluster of signs and symptoms. Syndromes are classified on age of
onset, seizure type(s), clinical and developmental features, EEG
abnormalities and MRI brain findings. It has therapeutic and prognostic
implications.
3. Operational (Practical) Clinical Definition of Epilepsy (any of the
following conditions):
• At least two unprovoked (or reflex) seizures occurring >24 h apart.
• One unprovoked (or reflex) seizure and a probability of further
seizures similar to the general recurrence risk (at least 60%) after two
unprovoked seizures, occurring over the next 10 years.
• Diagnosis of an epilepsy syndrome.
4. IMITATOR OF EPILEPSY
The first important step in
management of childhood
epilepsy is to differentiate
epileptic seizures from paroxysmal
non epileptic event
5. Approach to a child with a first seizure
-25-50 % unprovoked seizure in
child will recur
Routine investigation
- FBC,BUSE,Ca,Mg, RBS
-LP (if suspicious brain infection)
-Toxicology screening
-EEG
-Neuro imaging (MRI)
Treatment not required
Approach to a child with a epilepsy
Diagnosis of epilepsy mainly
clinical
detailed history of
seizure/video,past
history,developmental history,
family history
look for
dysmorphism,neurocutaneous
stigmata, thorough CNS and
developmental examination
-perform general and systemic
examination to look for clue of
underlying etiology
Investigation
-blood : FBC, RP,LFT, BLLOD
GLUCOSE,CALCIUM , MAGNESIUMTO
EXCLUDE METABOLIC CAUSE AND BEFORE
STARTING AED
-METABOLIC AND GENETIC STUDY IF
INDICATED
- EEG
- MRI
INDICATED IN : Epilepsy occurring in first
year of life,focal epilepsy, developmental
delay or regressin,difficult to
control,refractory epilepsy
8. Why the need for new classification?
• Use words that mean what they say
• Previous classification was based on anatomical basis
• but now accepted that epilepsy is a network disorder
(eg: neocortical, limbic)
• Places emphasis on symptoms and signs of the event (semiology)
– Sometimes supported by additional data: EEG, MRI, genes, antibodies, etc
– Is not based on EEG ictal or subclinical patterns
• Easier for clinicians to use
• Allow patients to understand terminology
9. Why is classifying epilepsy important?
▪ Children & family need a:
-diagnosis
-prognosis
-management plan (specific & precise to pt)
▪ Diagnosing epilepsy is not enough!!!
▪ Short and long term management of specific
epileptic syndrome differs markedly
▪ Can direct investigations and appropriate Tx
10. ▪level 1: Semiology / seizure type (is it seizure?)
▪level 2: Epilepsy type
▪level 3: Epilepsy syndrome
▪level 4: Aetiology
▪level 5: Co-morbidities ILAE task force Epilepsia2001, 2017
HOW TO APPROACH EPILEPSY
11. The “ DESSCRIBE “Approach
How do I approach epilepsy?“the DESSCRIBE approach”
▪level 1: D escription
E pileptic or non-epileptic episode(s)?
▪ level 2: S eizure type(s)?
▪ level 3: S yndrome
▪ level 4: C ause
▪ level 5: R elevent;
I mpairment
B ehavioural and emotion
E ducation issues?
12. level 1-Semiology (Epileptic seizure or not) =
D,E
• Need to decide if epileptic
seizure
• Crucial as 25% of patients
misdiagnosed as epileptic
• There are no gold standard
investigative tool to diagnose
epilepsy (EEG, MRI ….. Only
Supportive to confirm clinical
suspicion)
• Good clinical history taking
cornerstone of diagnosis of
epilepsy
• After taking history of event
(patient and witnesses); is it
consistent with epileptic seizure?
- Yes: appropriate Mx,
consider Ix (EEG,
MRI,etc)
- No: Consider differential
diagnosis, +/- other Ix
• Uncertain: wait & see, need more
info & time,observing natural Hx
important but takes time
▪ If not sure: say “uexplained
paroxysmal event”
▪ If not clear Hx, better to observe
patient rather
• than rush into diagnosis
14. Focal seizure
• Originate within
networks limited
to one
hemisphere
• May be
discretely
localized or more
widely
distributed
• Awareness or
impaired
awareness
Generalized seizures
• Originate at some
point within and
rapidly engage
bilaterally distributed
networks
• Can include cortical
and subcortical
structures but not
necessarily the entire
cortex
Unknown Seizures
• Unknown onset if no
supplementary information to
determine if onset focal or
generalized
• If child found by Mum having
bilateral tonic-clonic seizure in bed
but onset not witnessed; EEG and
MRI normal
= Unknown onset tonic-clonic sz
• If child found by Mum having
bilateraltonic-clonic sz in bed but
onset not witnessed; EEG showing
R parietal slowing, MRI R parietal
cortical dysplasia
= Focal to bilateral tonic-clonic sz
15.
16. ICTAL SEMIOLOGY: MOTOR SEIZURE
• Myoclonic jerks: v. brief muscular contractions
thatoccur singly / repeated only a few times
(<100ms)
• Spasms: widespread muscular contractions (< 2sec)
• Tonic: sustained muscle contraction (few sec–mins)
• Clonic: rhythmic myoclonus / repetitive myoclonus
involving same muscle groups approx 2-3 c/sec
• Atonic: sudden loss of erect posture
• Automatism: repetitive stereotypical voluntary
motor activity when cognition impaired
- Simple
- Complex
• Postural changes: adoption of posture (symmetrical,
asymmetrical)
ICTAL SEMIOLOGY: NON-MOTOR
SEIZURE
• Impaired awareness: altered conscious level
• Somatosensory
• Visual
• Olfactory
• Gustatory
• Auditory
• Autonomic
17. level 2 – Seizure type = S
• Epileptic seizures are usually
divided into
generalised and focal
• A generalised epileptic seizure is:
“A seizure whose initial semiology
indicates, or is consistent with, more
than minimal involvement of both
cerebral hemispheres”
• A focal epileptic seizure is:
“A seizure whose initial semiology
indicates, or is consistent with, initial
activation of only part of one
cerebral hemisphere”
18. Level 2: Epilepsy type
GENERALISED
EPILEPSY
• Made on clinical
grounds supported by
typical interictal EEG
findings :Typically show
generalized spike wave
on EEG
• NB: caution in patient
with GTCS and a normal
EEG
-These patients need to
have supportive evidence
of generalized epilepsy like
family history or myoclonic
jerks
FOCAL EPILEPSY
• Considered in
focal, (multi)focal
and also
hemispheric
epilepsies • New group as there are
patients with both epilepsies
• Diagnosis made on clinical
grounds supported by EEG
findings
– Both focal impaired awareness
seizures + generalized absence
seizures
– Interictal EEG: both GSW and
focal discharges but epileptiform
activity not required for the
diagnosis
• Examples include Dravet
syndrome and Lennox
Gastaut syndrome
COMBINED GENERALISED
AND FOCAL EPILEPSY:
19. Level 3: Epilepsy syndromes
An epileptic syndrome
is an epileptic disorder
characterized by a
cluster of signs and
symptoms. Syndromes
are classified on age of
onset, seizure type(s),
clinical and
developmental
features, EEG
abnormalities and MRI
brain findings. It has
therapeutic and
prognostic
implications.
20. level 4: Causes of epilepsy
• Idiopathic → genetic
• Symptomatic → structural, metabolic,(auto)immune, infectious
• Cryptogenic → abandoned replaced with unknown cause
21. Level 5- “Relevant Impairments, Behavioural &
emotional or Educational probs
• Majority of children with attend mainstream school; but studies
suggest 50% have some behavioural problem / receive educational
input
• Specific seizure syndromes (especially symptomatic) predispose child
to behavioural impairments:
-Infantile spasm, Complex focal: ASD, ADHD
-L Gastaut: social unresponsive, violent behaviours
-BECTS: attention deficit, mild cognitive problem
22. Example ILAE approach
• 1. (DE) Sz semiology
• 2. (S) Epilepsy type
• 3. (S) Epilepsy syndrome
• 4. (C) Cause
• 5. (RIBE) Additional
impairments
1. Cry out, trunk flexion
2. Generalised, tonic
3. Epileptic encephalopathy-
infantile spasm
4. Tuberous sclerosis
5. Developmental delay ,autistic
features
23. SUMMARY ILAE 2017 CLASSIFICATION OF EPILEPSIES
• Meant to make framework more straightforward
- Seizure type: assessing onset
- Epilepsy type
- Epilepsy syndrome
• Aetiology, aetiology, aetiology considered at all stages
• Retained IGE = CAE, JAE, JME, GTCSA
• Abandoned symptomatic generalised epilepsies replaced with
developmental and / or epileptic
encephalopathies
• Benign epilepsies replaced to self-limited epilepsies
24. Principle of antiepileptic drug (AED) therapy
for epilepsy
- Attempt to classify the seizure type and epilepsy syndrome
- Treatment recommended if ≥ 2 episodes
- Monotherapy as far as possible
- Choose most appropriate drug based on epilepsy syndrome, seizure type( if epilepsy syndrome
not identify yet and associated comorbidities
- Increased dose gradually until seizure controlled or maximum dose reached or side effect occur.
- Add on second drug if first drug failed, optimise second drug, then try to withdraw first drug
- Avoid starting female of child bearing potential syrup Valproate because of risk of teratogenicity
and neurodevelopmental impairment to unborn child.
- Trial of vitamin and co factor such as vitamin b6, biotin, folinic acid, should be considered in
infantile epilepsies not responding to AED
- With withdrew medication is planned,(generally after seizure free for 2 years) consideration
should be given to epilepsy syndrome, likely prognosis, and individual circumstances before
attempting slow withdrawal of medication over 3-6 month.
- If seizure recur, last dose reduction is reserved and medical advice sought.
25. Key points for rational polytherapy
• Key principle: “Start low, go slow”
– Give gradual titration up plan
– Ensure non-medication factors optimized (sleepquality, stress)
• The selected AED should not be abandoned too early
• The correct AED is the smallest one that achieves sz control without
ADRs
• Children more susceptible than adults to specific ADRs
• Prevent over-medication
26.
27.
28. Definition of status epilepticus (ILAE 2015)
‘SE is due failure of the mechanisms responsible for seizure termination or
from the initiation of mechanisms which lead to abnormally prolonged
seizure (after time point 1). it is a condition that can have long term
consequences (after time point 2), including neuronal death, neuronal injury,
and alteration of neuronal networks’
• Two conceptual time points with operational dimensions:
– Time point 1 (TP1): point beyond which a seizure should be classified as
‘continuous seizure activity’ indicates the moment when treatment is
indicated
– Time point (TP2): during ongoing continuous seizure activity denotes the
juncture at which the risk of long-term neurological sequelae develops
• Determines the aggressiveness of treatment
29. INTRODUCTION
New Definition of SE as Proposed by the
International League Against Epilepsy (2015)
Status epilepticus type Time 1
(Treatment
Commenced)
Time 2
(Consequences
Expected)
Tonic-clonic 5min 30 min
Focal with impaired
consciousness
10 min >60 min
Absence 15 min unknown
30.
31.
32. Summary
• Good clinical history crucial to diagnose sz
- Never use EEG to solely diagnose epilepsy
• Classification is important – allows methodical
approach to testing, treatment and prognosis
• AED is chosen based on epilepsy type / syndrome